Cargando…

Type 1 diabetes alters ischemia-induced gene expression

Peripheral Artery Disease (PAD) is a chronic, activity-limiting disease that is caused by atherosclerotic occlusion of blood vessels outside the heart. Type 1 Diabetes (T1D) not only increases an individual’s likelihood of developing PAD, but also contributes to poor clinical outcomes after PAD mani...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peravali, Rahul, Gunnels, Lucas, Alleboina, Satyanarayana, Gerling, Ivan C., Dokun, Ayotunde O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6279996/ https://www.ncbi.nlm.nih.gov/pubmed/30555789 http://dx.doi.org/10.1016/j.jcte.2018.11.003

Ejemplares similares

SAT-044 Diabetes Alters Ischemia-Induced Gene Expression
por: Ariganjoye, Folabi, et al.
Publicado: (2019)

In experimental peripheral arterial disease, type 2 diabetes alters post-ischemic gene expression
por: Peravali, Rahul, et al.
Publicado: (2019)

OR14-06 Inhibition of Protein Kinase C-beta2 Phosphorylation Restores Nuclear Factor-Kappa B Activation and Improves Peripheral Arterial Disease in Diabetes
por: Alleboina, Satyanarayana, et al.
Publicado: (2020)

BAG3 Attenuates Ischemia-Induced Skeletal Muscle Necroptosis in Diabetic Experimental Peripheral Artery Disease
por: Mani, Arul M., et al.
Publicado: (2022)

Individuals with Peripheral Artery Disease (PAD) and Type 1 Diabetes Are More Likely to Undergo Limb Amputation than Those with PAD and Type 2 Diabetes
por: Jain, Nidhi, et al.
Publicado: (2020)

SUN-069 Differences in Treatment of Peripheral Arterial Disease Procedures in Hospitalized Patients with Type 1 or 2 Diabetes
por: Jain, Nidhi, et al.
Publicado: (2019)

Diabetes mellitus in peripheral artery disease: Beyond a risk factor
por: Singh, Madhu V., et al.
Publicado: (2023)

SUN-078 ADAM12 Is a Direct Target of mir29a: Implications for Impaired Post-Ischemic Adaptation in Diabetes
por: Wong, Thomas, et al.
Publicado: (2019)

BLNK/BTK: Novel Components in the NF-kappa B Pathways of Endothelial Cells in Diabetic Condition
por: Singh, Madhu V, et al.
Publicado: (2021)

Therapeutically targeting oncogenic CRCs facilitates induced differentiation of NB by RA and the BET bromodomain inhibitor
por: Alleboina, Satyanarayana, et al.
Publicado: (2021)

FRI625 Diabetic Ischemic Skeletal Muscle Injury Occurs Through Pkc-beta/sp1 Regulation Of Bag3 Expression
por: Murugan Mani, Arul, et al.
Publicado: (2023)

MON-448 Detection of Thyroid Cancer Recurrence in Patients with Positive Thyroglobulin Antibody Receiving Immunoglobulin Therapy
por: Taiwo, Adeyinka, et al.
Publicado: (2020)

In a Mouse Model of Type 2 Diabetes and Peripheral Artery Disease, Modulation of MirR29a and ADAM12 Reduced Post -Ischemic Skeletal Muscle Injury, Improved Perfusion Recovery and Skeletal Muscle Function
por: Lamin, Victor, et al.
Publicado: (2021)

THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

microRNA‐29a Regulates ADAM12 Through Direct Interaction With ADAM12 mRNA and Modulates Postischemic Perfusion Recovery
por: Lamin, Victor, et al.
Publicado: (2022)

SAT-632 Involvement of NF-κB-p65 in BAG3 Regulation After Stress Stimuli
por: Dhanabalan, Karthik, et al.
Publicado: (2020)

Modulation of miR-29a and ADAM12 Reduces Post-Ischemic Skeletal Muscle Injury and Improves Perfusion Recovery and Skeletal Muscle Function in a Mouse Model of Type 2 Diabetes and Peripheral Artery Disease
por: Lamin, Victor, et al.
Publicado: (2021)

SUN-585 A Case of Atypical Myxedema in Hypothyroidism
por: Wynn, Anne, et al.
Publicado: (2019)

RF04 | PSUN163 In High Glucose Exposed Endothelial Cells BTK is a Novel Component of the Nuclear Factor-Kappa B Pathway
por: Singh, Madhu, et al.
Publicado: (2022)

Candidate genes within known QTL of type 1 diabetes from mouse models
por: Gu, Weikuan, et al.
Publicado: (2008)

THU585 Non-alcoholic Fatty Liver Disease (NAFLD), A Silent But Emerging Problem In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Molecular pathway alterations in CD4 T-cells of nonobese diabetic (NOD) mice in the preinsulitis phase of autoimmune diabetes
por: Kakoola, Dorothy N., et al.
Publicado: (2014)

Development of Type 1 Diabetes may occur through a Type 2 Diabetes mechanism
por: Josefsen, Knud, et al.
Publicado: (2022)

Patients With Obesity-Related Hypertension Treated With Renin-Angiotensin-Aldosterone System Antagonists Exhibit Lower Mortality And Less Severe COVID-19: A Retrospective Study
por: Kamalumpundi, Vijayvardhan, et al.
Publicado: (2021)

Associação entre o Antagonismo do Sistema Renina-Angiotensina-Aldosterona e a Mortalidade Relacionada à COVID-19 em Pacientes com Hipertensão Relacionada ao Sobrepeso/Obesidade: um Estudo Retrospectivo de Coorte
por: Shams, Elham, et al.
Publicado: (2023)

PDE12 in type 1 diabetes
por: Tekin, Hasim, et al.
Publicado: (2022)

The National Clinical Care Commission Report to Congress: Leveraging Federal Policies and Programs to Improve Diabetes Treatment and Reduce Complications
por: Greenlee, M. Carol, et al.
Publicado: (2023)

Approaches to reduce false positives and false negatives in the analysis of microarray data: applications in type 1 diabetes research
por: Wu, Jian, et al.
Publicado: (2008)

The Relationship between Acute and Chronic Pancreatitis with Pancreatic Adenocarcinoma: Review
por: Alhobayb, Tamara, et al.
Publicado: (2021)

Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes
por: Apaolaza, Paola S., et al.
Publicado: (2021)

Global disability burden and its predictors among adult Nigerians living with Type-2 diabetes
por: Oyewole, Olufemi O, et al.
Publicado: (2019)

VEGF alleviates lower limb ischemia in diabetic mice by altering muscle fiber types
por: Jia, Lijing, et al.
Publicado: (2022)

Youth With Type 1 Diabetes Experienced a Higher Level of Anxiety During the COVID-19 Pandemic Compared to Healthy Control; A Cross-Sectional Study
por: Wade, Caroline, et al.
Publicado: (2021)

Alterations in lung gene expression in streptozotocin-induced diabetic rats
por: van Lunteren, Erik, et al.
Publicado: (2014)

Burden of disability in type 2 diabetes mellitus and the moderating effects of physical activity
por: Oyewole, Olufemi O, et al.
Publicado: (2023)

Genetic and Molecular Basis of QTL of Diabetes in Mouse: Genes and Polymorphisms
por: Gao, Peng, et al.
Publicado: (2008)

Does Therapy With Anti–TNF-α Improve Glucose Tolerance and Control in Patients With Type 2 Diabetes?
por: Gupta-Ganguli, Malini, et al.
Publicado: (2011)

Differences in gene expression profiles between individual islets from case #6213
por: Lenchik, Nataliya I, et al.
Publicado: (2014)

Altered Gene Expression Profiles in the Lungs of Streptozotocin-induced Diabetic Mice
por: Kim, Jung-Hyun, et al.
Publicado: (2020)

What the HLA-I!—Classical and Non-classical HLA Class I and Their Potential Roles in Type 1 Diabetes
por: Wyatt, Rebecca C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_bk5gd3cr5nknkfir8ccko7kjb1